Patient Group Direction: Ciprofloxacin under 12 (Anthrax)

Document first published:
Page updated:
Topic:
,
Publication type:

Patient Group Direction (PGD) for the initial supply of ciprofloxacin tablets or suspension to children aged under 12 years of age with known or suspected exposure to anthrax.